Methods of administering 3,4-diaminopridine

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11845977
APP PUB NO 20230295685A1
SERIAL NO

18322342

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided herein are methods of determining NAT acetylation status of a subject with a 3,4-DAP-sensitive disease, methods of selecting a dose of 3,4-DAP or a pharmaceutically acceptable salt thereof adjusted to a subject's acetylation status, methods of administering 3,4-diaminopyridine or a pharmaceutically acceptable salt thereof to a patient in need thereof, and methods of treating 3,4-DAP sensitive diseases.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SERB SABRUSSELS

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Garovoy, Marvin R Sausalito, US 19 71
Haroldsen, Peter E Pacifica, US 11 39
Musson, Donald G Larkspur, US 13 74

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jun 19, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 19, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 19, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00